Change-Plane Analysis for Subgroup Detection and Sample Size Calculation

References

• Andrews, D. W. (1993), “Tests for Parameter Instability and Structural Change With Unknown Change Point,” Econometrica: Journal of the Econometric Society , 61, 821–856.
   Web of Science ®Google Scholar
• Andrews, D. W. (2001), “Testing When a Parameter is on the Boundary of the Maintained Hypothesis,” Econometrica , 69, 683–734.
   Web of Science ®Google Scholar
• Assmann, S. F. , Pocock, S. J. , Enos, L. E. , and Kasten, L. E. (2000), “Subgroup Analysis and Other (mis) Uses of Baseline Data in Clinical Trials,” The Lancet , 355, 1064–1069.
   PubMed Web of Science ®Google Scholar
• Bai, J. (1997), “Estimation of a Change Point in Multiple Regression Models,” Review of Economics and Statistics , 79, 551–563.
   Web of Science ®Google Scholar
• Bonetti, M. , and Gelber, R. D. (2004), “Patterns of Treatment Effects in subsets of Patients in Clinical Trials,” Biostatistics , 5, 465–481.
   PubMed Web of Science ®Google Scholar
• Borm, G. F. , Fransen, J. , and Lemmens, W. A. (2007), “A Simple Sample Size Formula for Analysis of covariance in Randomized Clinical Trials,” Journal of Clinical Epidemiology , 60, 1234–1238.
   PubMed Web of Science ®Google Scholar
• Brookes, S. T. , Whitely, E. , Egger, M. , Smith, G. D. , Mulheran, P. A. , and Peters, T. J. (2004), “Subgroup Analyses in Randomized Trials: Risks of Subgroup-Specific Analyses; Power and Sample Size for the Interaction Test,” Journal of Clinical Epidemiology , 57, 229–236.
   PubMed Web of Science ®Google Scholar
• Cai, T. , Tian, L. , Wong, P. H. , and Wei, L. (2011), “Analysis of Randomized Comparative Clinical Trial Data for Personalized Treatment Selections,” Biostatistics , 12, 270–282.
   PubMed Web of Science ®Google Scholar
• Cui, L. , James Hung, H. , Wang, S. J. , and Tsong, Y. (2002), “Issues Related to Subgroup Analysis in Clinical Trials,” Journal of Biopharmaceutical Statistics , 12, 347–358.
   PubMedGoogle Scholar
• Davies, R. B. (1977), “Hypothesis Testing When a Nuisance Parameter is Present Only Under the Alternative,” Biometrika , 64, 247–254.
   Web of Science ®Google Scholar
• Davies, R. B. (1987), “Hypothesis Testing When a Nuisance Parameter is Present Only Under the Alternative,” Biometrika , 74, 33–43.
   Web of Science ®Google Scholar
• Foster, J. C. , Taylor, J. M. , and Ruberg, S. J. (2011), “Subgroup Identification From Randomized Clinical Trial Data,” Statistics in medicine , 30, 2867–2880.
   PubMed Web of Science ®Google Scholar
• Hammer, S. M. , Katzenstein, D. A. , Hughes, M. D. , Gundacker, H. , Schooley, R. T. , Haubrich, R. H. , Henry, W. K. , Lederman, M. M. , Phair, J. P. , Niu, M. , et al. (1996), “A Trial Comparing Nucleoside Monotherapy With Combination Therapy in HIV-Infected Adults With cd4 Cell Counts From 200 to 500 Per Cubic Millimeter,” New England Journal of Medicine , 335, 1081–1090.
   PubMed Web of Science ®Google Scholar
• Kuk, A. , Li, J. , and Rush, A. J. (2010), “Recursive Subsetting to Identify Patients in the Star* d: A Method to Enhance the Accuracy of Early Prediction of Treatment Outcome and to Inform Personalized Care,” The Journal of Clinical Psychiatry , 71, 1502–1508.
   PubMed Web of Science ®Google Scholar
• Liang, K.-Y. , Self, S. G. , and Liu, X. (1990), “The Cox Proportional Hazards Model With Change Point: An Epidemiologic Application,” Biometrics , 46, 783–793.
   PubMed Web of Science ®Google Scholar
• Lu, W. , Zhang, H. H. , and Zeng, D. (2013), “Variable Selection for Optimal Treatment Decision,” Statistical Methods in Medical Research , 22, 493–504.
   PubMed Web of Science ®Google Scholar
• Murphy, S. A. (2003), “Optimal Dynamic Treatment Regimes,” Journal of the Royal Statistical Society , Series B, 65, 331–355.
   Google Scholar
• Robins, J. M. (2004), “Optimal Structural Nested Models for Optimal Sequential Decisions,” in Proceedings of the Second Seattle Symposium in Biostatistics, New York: Springer, pp. 189–326.
   Google Scholar
• Robins, J. M. , and Rotnizky, A. (2001), Comment on the Bickel and Kwon Article, “Inference for Semiparametric Models: Some Questions and an Answer,” Statistica Sinica , 11, 920–936.
   Web of Science ®Google Scholar
• Rothwell, P. M. (2005), “Subgroup Analysis in Randomised Controlled Trials: Importance, Indications, and Interpretation,” The Lancet , 365, 176–186.
   PubMed Web of Science ®Google Scholar
• Shen, J. , and He, X. (2015), “Inference for Subgroup Analysis With a Structured Logistic-Normal Mixture Model,” Journal of the American Statistical Association , 110, 303–312.
   Web of Science ®Google Scholar
• Song, X. , and Pepe, M. S. (2004), “Evaluating Markers for Selecting a Patient’s Treatment,” Biometrics , 60, 874–883.
   PubMed Web of Science ®Google Scholar
• Tsiatis, A. (2006), Semiparametric Theory and Missing Data, New York: Springer Science & Business Media.
   Google Scholar
• Van der Vaart, A. W. (2000), Asymptotic Statistics (vol. 3), Cambridge, UK: Cambridge University Press.
   Google Scholar
• Wang, R. , Lagakos, S. W. , Ware, J. H. , Hunter, D. J. , and Drazen, J. M. (2007), “Statistics in Medicine: Reporting of Subgroup Analyses in Clinical Trials,” New England Journal of Medicine , 357, 2189–2194.
   PubMed Web of Science ®Google Scholar
• Yusuf, S. , Wittes, J. , Probstfield, J. , and Tyroler, H. A. (1991), “Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials,” JAMA , 266, 93–98.
   PubMed Web of Science ®Google Scholar
• Zhao, L. , Tian, L. , Cai, T. , Claggett, B. , and Wei, L.-J. (2013), “Effectively Selecting a Target Population for a Future Comparative Study,” Journal of the American Statistical Association , 108, 527–539.
   PubMed Web of Science ®Google Scholar